重新审视汞:硒在汞毒性病理生理中的作用
该综述检索Medline/PubMed、Toxline、Google Scholar和Google,初检获2018条文献,排除未评估硒状态或仅评估环境状态者后约500条,最终选取117篇最相关文献。汞对硒基团的亲和力比对巯基高数个数量级,汞与巯基结合主要涉及跨膜转运、组织分布和排泄增强,但不能解释氧化应激、钙稳态失衡或特异性器官损伤。汞结合并永久抑制硫氧还蛋白系统(硫氧还蛋白还原酶1和2)及谷胱甘肽-谷氧还蛋白系统(谷胱甘肽过氧化物酶)的硒位点,破坏细胞内氧化还原环境。硒对汞毒性有保护作用但有局限,部分取决于汞形态;补硒已被证明可恢复硒蛋白功能并降低汞毒性,但受汞形态(甲基汞毒性改善较差)和汞剂量限制。
要点
- 汞对硒基团的亲和力比巯基高数个数量级,汞与巯基结合主要涉及转运、分布和排泄,不能解释氧化应激和器官损伤。
- 汞结合并永久抑制硫氧还蛋白还原酶1、2和谷胱甘肽过氧化物酶的硒位点,破坏细胞内氧化还原环境,导致活性氧增多、钙稳态失衡和线粒体损伤。
- 甲基汞是硫氧还蛋白系统更强的抑制剂,部分解释其神经毒性更强。
- 硒对汞毒性的保护作用受汞形态和剂量限制,对甲基汞毒性的改善较差。
- 补硒已被证明可恢复硒蛋白功能并降低汞毒性,但存在包括汞形态和汞剂量在内的若干重要局限。
研究设计与关键结果
- 综述检索Medline/PubMed、Toxline、Google Scholar和Google,初检获2018条文献,排除未评估硒状态或仅评估环境状态者后约500条,最终选取117篇最相关文献。
- 汞对硒基团亲和力比巯基高数个数量级;汞与巯基结合主要涉及跨膜转运、组织分布和排泄增强,但不解释氧化应激、钙稳态失衡或特异性器官损伤。
- 汞结合并永久抑制硫氧还蛋白还原酶1、2和谷胱甘肽过氧化物酶的硒位点,破坏细胞内氧化还原环境;其他可能靶硒蛋白包括硒蛋白P、K和T。
- 甲基汞是硫氧还蛋白系统更强的抑制剂,部分解释其神经毒性更强;汞还可耗尽硒储备,阻碍硒蛋白再生。
- 硒降低汞毒性可能涉及:促进有机汞脱甲基为无机汞、汞再分布至较不敏感靶器官、与无机汞形成不溶性稳定惰性Hg:Se复合物、减少胃肠道汞吸收、补充硒储备、恢复靶硒蛋白活性。
- 硒是否增加或阻碍汞排泄证据矛盾,但增加汞排泄似乎不是硒的主要作用;补硒已被证明可恢复硒蛋白功能并降低汞毒性,局限包括汞形态(甲基汞毒性改善较差)和汞剂量。
证据类型、等级与局限
- 证据类型:综述,最终选取117篇最相关文献。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,既往提出的硒对汞毒性的「保护作用」可能相反;汞的作用是造成硒缺乏状态并直接抑制硒控制细胞内氧化还原环境的作用。
- 作者认为,补硒虽有局限,可能在恢复充足硒状态和减轻汞毒性方面有益。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「适用人群与场景」「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: There is increasing evidence that the pathophysiological target of mercury is in fact selenium, rather than the covalent binding of mercury to sulfur in the body's ubiquitous sulfhydryl groups. The role of selenium in mercury poisoning is multifaceted, bidirectional, and central to understanding the target organ toxicity of mercury.
METHODS: An initial search was performed using Medline/PubMed, Toxline, Google Scholar, and Google for published work on mercury and selenium. These searches yielded 2018 citations. Publications that did not evaluate selenium status or evaluated environmental status (e.g., lake or ocean sediment) were excluded, leaving approximately 500 citations. This initial selection was scrutinized carefully and 117 of the most relevant and representative references were selected for use in this review. Binding of mercury to thiol/sulfhydryl groups: Mercury has a lower affinity for thiol groups and higher affinity for selenium containing groups by several orders of magnitude, allowing for binding in a multifaceted way. The established binding of mercury to thiol moieties appears to primarily involve the transport across membranes, tissue distribution, and enhanced excretion, but does not explain the oxidative stress, calcium dyshomeostasis, or specific organ injury seen with mercury. Effects of mercury on selenium and the role this plays in the pathophysiology of mercury toxicity: Mercury impairs control of intracellular redox homeostasis with subsequent increased intracellular oxidative stress. Recent work has provided convincing evidence that the primary cellular targets are the selenoproteins of the thioredoxin system (thioredoxin reductase 1 and thioredoxin reductase 2) and the glutathione-glutaredoxin system (glutathione peroxidase). Mercury binds to the selenium site on these proteins and permanently inhibits their function, disrupting the intracellular redox environment. A number of other important possible target selenoproteins have been identified, including selenoprotein P, K, and T. Impairment of the thioredoxin and glutaredoxin systems allows for proliferation intracellular reactive oxygen species which leads to glutamate excitosis, calcium dyshomeostasis, mitochondrial injury/loss, lipid peroxidation, impairment of protein repair, and apoptosis. Methylmercury is a more potent inhibitor of the thioredoxin system, partially explaining its increased neurotoxicity. A second important mechanism is due to the high affinity of mercury for selenium and the subsequent depletion of selenium stores needed for insertion into de novo generation of replacement selenoproteins. This mercury-induced selenium deficiency state inhibits regeneration of the selenoproteins to restore the cellular redox environment. The effects of selenium on mercury and the role this plays in biological response to mercury: Early research suggested selenium may provide a protective role in mercury poisoning, and with limitations this is true. The roles selenium plays in this reduction of mercury toxicity partially depends on the form of mercury and may be multifaceted including: 1) facilitating demethylation of organic mercury to inorganic mercury; 2) redistribution of mercury to less sensitive target organs; 3) binding to inorganic mercury and forming an insoluble, stable and inert Hg:Se complex; 4) reduction of mercury absorption from the GI tract; 5) repletion of selenium stores (reverse selenium deficiency); and 6) restoration of target selenoprotein activity and restoring the intracellular redox environment. There is conflicting evidence as to whether selenium increases or hinders mercury elimination, but increased mercury elimination does not appear to be a major role of selenium. Selenium supplementation has been shown to restore selenoprotein function and reduce the toxicity of mercury, with several significant limitations including: the form of mercury (methylmercury toxicity is less responsive to amelioration) and mercury dose.
CONCLUSIONS: The interaction with selenium is a central feature in mercury toxicity. This interaction is complex depending on a number of features such as the form of mercury, the form of selenium, the organ and dose. The previously suggested "protective effect" of selenium against mercury toxicity may in fact be backwards. The effect of mercury is to produce a selenium deficiency state and a direct inhibition of selenium's role in controlling the intracellular redox environment in organisms. Selenium supplementation, with limitations, may have a beneficial role in restoring adequate selenium status from the deficiency state and mitigating the toxicity of mercury.
参考来源
- Spiller HA. Rethinking mercury: the role of selenium in the pathophysiology of mercury toxicity. Clin Toxicol (Phila). 2017. PMID: 29124976. doi:10.1080/15563650.2017.1400555
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。